Valuation and Outlook. Growth (%) PAT (Rs cr)

Similar documents
Consolidated Sales (Cr) Growth EBITDA (Cr) Margin PAT Margin EPS (Rs) P/E RoE

Initiating Coverage. Uflex Ltd.

Punjab National Bank

DCB Bank Ltd. 1 P a g e

South Indian Bank. Institutional Equities. 4QFY18 Result Update. Asset Quality Pain To Ease Hereafter BUY. 15 May 2018

LIC Housing Finance Ltd

Punjab National Bank

Gillette India. Institutional Equities. 1QFY18 Result Update

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance

Federal Bank BUY. Performance Highlights. Target Price. 1QFY2018 Result Update Banking. Stock Info Sector

Institutional Equities

Colgate-Palmolive (India)

Indian Oil Corporation

Jamna Auto Industries

Dalmia Bharat Enterprises

2,09,057 1,85,859 2,17, (4.1) NIM

Sanofi India. Institutional Equities. 3QCY18 Result Update. Robust Performance BUY

Karnataka Bank. Institutional Equities. 4QFY18 Result Update. Plucky Bank And Low Hanging Fruit BUY. 17 May Reuters: KBNK.NS; Bloomberg: KBL IN

LIC Housing Finance BUY. Performance Highlights. CMP Target Price `532 `630. 3QFY2017 Result Update HFC. 3-Year Daily Price Chart

Power Mech Projects. Institutional Equities. 2QFY19 Result Update BUY. Strong Order Book Drives Robust Execution

BUY. ICICI Bank RETAIL EQUITY RESEARCH. Banking. ddd******* GEOJIT Research. Strong traction in retail segment continues

ITC. Institutional Equities. 4QFY18 Result Update. Tracking Expectations ACCUMULATE. Sector: FMCG CMP: Rs286 Target Price: Rs290 Upside: 1%

EBITDA 5,076 3, , EBITDA

ICICI Bank BUY. Performance Highlights. CMP Target Price `328 `416. 3QFY2018 Result Update Banking. 3-year price chart. Key financials (Standalone)

Manappuram Finance. Institutional Equities. 3QFY18 Result Update. The Glitter Is Back In Gold Loans BUY. 9 February 2018

Reduce. Punjab National Bank Banking RETAIL EQUITY RESEARCH. Not out of the woods. GEOJIT BNP PARIBAS Research. 10 th August 2016 Q1FY17 RESULT UPDATE

ICICI Bank BUY. Performance Highlights. CMP Target Price `307 `411. 1QFY2019 Result Update Banking. 3-year price chart. Key financials (Standalone)

HDFC Bank BUY. Performance Highlights. CMP `2,145 Target Price `2,500. Q3FY2019 Result Update Banking. 3-year price chart. Key financials (Standalone)

PNB Housing Finance. Institutional Equities. 4QFY18 Result Update BUY. Continued Display of Embedded Scalability. 4 May 2018

Financial summary. Year

HDFC Bank BUY. Performance Highlights. CMP `1,965 Target Price `2,350. Q2FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials

18,948 15,784 18, NIM

State Bank of India (SBI) Banking. BUY Rating as per Large Cap 12 month investment period RETAIL EQUITY RESEARCH

HDFC Bank BUY. Operating performance strong; improved NIM. CMP `2,268 Target Price `2,500. Q4FY2019 Result Update Banking. 3-year price chart

Indostar Capital Finance Ltd.

BUY. State Bank of India (SBI) Banking RETAIL EQUITY RESEARCH. GEOJIT BNP PARIBAS Research. CMP Rs259 TARGET Rs284 RETURN 10% 22 nd August 2016

NESCO. Institutional Equities. Event Update. Revenues From Bombay Exhibition Centre May Take A Hit BUY

Axis Bank Ltd. For private circulation only. Volume No.. III Issue No October 08, 2018

Bharat Financial Inclusion

Initiating Coverage. Vaibhav Global Ltd. (VGL) BUY Back On Track Huge Potential Ahead. 1 P a g e

State Bank of India. Institutional Equities. 3QFY19 Result Update BUY

ICICI Bank BUY. Performance Highlights. CMP Target Price `343 `460. Q3FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials

9,251 7,812 8, NIM

Recommendation BUY Snapshot CMP (01/08/2011) Rs. 85 Target Rs. 129

BUY. State Bank of India (SBI) Banking RETAIL EQUITY RESEARCH. Outlook getting better. CMP Rs278 TARGET Rs310 RETURN 12% 17 th November 2016

ICICI BANK Ltd. BUY CMP (Rs.) 334 Target (Rs.) 382 Potential Upside 15% Tide set to turn favourably... For private circulation only

HDFC Bank. BUY CMP (Rs.) 1,807 Target (Rs.) 2,000 Potential Upside 11%

Punjab National Bank

9,500 7,914 8, NIM

ICICI Bank Banking BUY RETAIL EQUITY RESEARCH

FY17 FY18 FY19E FY20E

9,807 8,007 9, NIM

Punjab National Bank

HDFC Bank Banking BUY RETAIL EQUITY RESEARCH

PNB Housing Finance. Institutional Equities. 2QFY19 Result Update BUY. Relatively Soft Quarter Not Structural In Nature.

RBL Bank Ltd. Banking. ACCUMULATE Rating as per Mid Cap 12 months investment period RETAIL EQUITY RESEARCH

Institutional Equities

FY17 FY18 FY19E FY20E

Bank of Baroda (BOB) Banking. BUY Rating as per Large Cap 12 month investment period RETAIL EQUITY RESEARCH

HDFC Bank Banking. BUY Rating as per Large Ccap 12 month investment period RETAIL EQUITY RESEARCH

Muthoot Finance. Institutional Equities. 3QFY18 Result Update. Funding Cost Decline Combines With Operating Leverage BUY.

93,707 77,814 90, NIM

HOLD Rating as per Large Cap 12 month investment period

Axis Bank Banking. HOLD Rating as per Large Cap 12 months investment period RETAIL EQUITY RESEARCH

3,746 2,551 3, NIM

South Indian Bank. Institutional Equities. 1QFY19 Result Update. Performance Troughs, Pessimism Peaks BUY. 23 July 2018

Dewan Housing Finance

Indian Oil Corporation

Punjab National Bank NEUTRAL. Performance Highlights CMP. `134 Target Price - 2QFY2016 Result Update Banking November 13, Investment Period -

Punjab National Bank

Mold-Tek Packaging. Institutional Equities. Conference Update. Promising Growth Outlook BUY

Bata India. Institutional Equities. 1QFY19 Result Update BUY

Institutional Equities

Federal Bank Ltd. Banking/Finance. Accumulate RETAIL EQUITY RESEARCH

Axis Bank BUY. CMP Target Price `620 `750. Update Bank. Earnings to normalize with stabilizing credit costs. 3-year price chart.

Institutional Equities

State Bank of India (SBI)

Robust results, TLT margins improved profitability.

Institutional Equities

Punjab National Bank. CMP: INR716 TP: INR950 Buy

Punjab National Bank

Bank of Baroda (BOB)

Equitas Holdings. Rating: Target price: ABV: Target CMP. Rating. Rs Rs. 226 BUY

Bajaj Finance Limited (BFL) NBFC. BUY Rating as per Large Cap 12 months investment period RETAIL EQUITY RESEARCH

Nestle India. Institutional Equities. 1QCY18 Result Update. Resurgence Continues BUY. Sector: FMCG CMP: Rs8,981 Target Price: Rs10,700 Upside: 19%

HDFC Bank (HDFCB IN) Continue to perform strong

Federal Bank BUY RETAIL EQUITY RESEARCH

City Union Bank BUY. 24 February 2016 INR82

Buy Rating as per Mid Cap 12months investment period

Institutional Equities

Union Bank of India NEUTRAL. Performance Highlights CMP. `393 Target Price - 2QFY2011 Result Update Banking. Investment Period -

DCB Bank. Strong performance, valuation comforting

Operating expenses tracked lower than core total income growth as ABL displayed continued

State Bank of India (SBI) Banking BUY RETAIL EQUITY RESEARCH

Muthoot Finance. Institutional Equities. 2QFY18 Result Update BUY

HFC NEUTRAL. Performance Highlights CMP. `678 Target Price - 1QFY2013 Result Update HFC. Investment Period - Key financials

State Bank of India (SBI) Banking. BUY Rating as per Large Cap 12 month investment period RETAIL EQUITY RESEARCH

Ujjivan Financial Services Ltd Banking/Finance. Accumulate RETAIL EQUITY RESEARCH

Mangalam Cement. Institutional Equities. 3QFY18 Result Update. Higher Operating costs Hurt Performance BUY

Muthoot Finance. Institutional Equities. 1QFY18 Result Update. Gold Loan Business Continues To Glitter BUY. 10 August 2017

Transcription:

Feb-18 May-18 Aug-18 Nov-18 Feb-19 4 Recommendation Hold CMP Rs. 67 Target Price Rs. 90 Sector Stock Details Banking BSE Code 590003 NSE Code Bloomberg Code KARURVYSYA KVB IN Market Cap (Rs Cr) Rs. 5,355 Free Float (%) 97.9% 52- week H/L (Rs) 101/63 Avg. volume (BSE+NSE) 1304680 Face Value (Rs) 2 Div per share (FY 18) 0.60 Shares o/s (Crs) 72.7 Relative Performance 1Mth 3Mth 1Yr KVB -27% -17% -34% Sensex -25% -20% -40% 110 100 90 80 70 60 Shareholding Pattern Dec 18 Promoters Holding 2.1% Institutional (Incl. FII) 40.9% Public & others 57.0% Jehan Bhadha (+91 22 6273 8174) Research Analyst jehankersi.bhadha@nirmalbang.com Dnyanada Vaidya (+91 22 6273 8186) Research Associate dnyanada.vaidya@nirmalbang.com Year NII (Rs cr) Growth (%) PBP (Rs cr) Elevated slippages and credit costs in SME and Corporate book to persist in FY20E KVB reported a muted quarter on the asset quality front; with profits plummeting on the back of significantly higher provisions Advances stood at Rs. 47,766 Cr vs Rs. 44,836 Cr in a growth of 7% YoY. Retail loans exhibited a robust growth of 25% YoY contributing 19% to the overall advances. The bank chose to grow the Agri, SME and corporate book cautiously, with each contributing 17%, 35% and 28% resp. We expect loan growth of 14% CAGR over FY19-21E. NIMs were higher 3 bps QoQ at 3.60%. They were at 3.76% YoY resulting in NII growth of just 3% YoY. NIMs are expected to inch higher in coming quarters, with cost of funds coming down. Total income also grew by 7% YoY supported by 16% growth in non-interest income. Opex growth stood at 14% YoY. Cost/income ratio showed an improvement sequentially improving by 267 bps; however increased by 300 bps YoY to 49.4%. Employee expenses increased by 29% YoY due to higher provisions for employee retirement benefit; while other expenses increased by 3% YoY. PPP remained flat at Rs. 425 Cr YoY. Provisions during the quarter stood at Rs. 400 Cr vs Rs. 325 Cr in and Rs. 213 cr in. The quarterly provisioning rate was higher mainly on account of provisioning on the IL&FS exposure of Rs. 314 Cr. Credit cost for the quarter remained elevated at 3.5% vs 1.8% QoQ and 3.1% YoY. Credit costs are expected to remain elevated in FY20 on the back of expectations of an increase in slippages and an increase in an calculated PCR from current levels of ~43% to levels of ~60% over next one to two years. The bank reported Net Profit of Rs. 21 Cr vs Rs. 72 Cr in (-70% YoY) and Rs. 84 Cr in. Valuation and Outlook Sharpening focus on the retail and SME segments while building revenue as well as profit momentum (loan/pat CAGR of 14%/85%, respectively, over FY19-21E) and transformation into a granular and higher RoE business combined with cheap valuations at 1.2x FY21 ABV provides decent scope for re-rating. However, continued elevated stress in the corporate & SME book should result in the bank recognizing this pending stress which would mean elevated credit costs for FY20E. We thus revise our rating to Hold on the stock with a price target of Rs. 90, based on 1.5x FY21E ABV (33% discount to CUB). PAT (Rs cr) Growth (%) EPS (Rs) PE (x) Adj BVPS (Rs) FY18 2,298 11% 1,777 346-43% 4.8 16.6 60.6 1.3 6.1% FY19E 2,410 5% 1,755 247-29% 3.1 21.7 52.2 1.3 3.9% FY20E 2,656 10% 2,021 674 173% 8.4 7.9 54.3 1.2 10.0% FY21E 3,030 14% 2,342 841 25% 10.5 6.4 58.2 1.2 11.4% P/ABV (x) RoE (%) 1 P a g e

Quarterly Results Particulars (Rs. Cr) Comments Interest Earned 1384 1402 1422 1491 1443 1457 1443 Interest Expended 846 847 861 848 859 878 862 Net Interest Income 539 555 562 643 584 579 581 Growth 12% 12% 9% 11% 8% 4% 3% NIMs 3.76% 3.81% 3.76% 3.86% 3.65% 3.57% 3.60% NIMs have stabilized and should inch higher in coming quarter. Other Income 236 230 225 209 255 176 260 % of total income 30% 29% 29% 25% 30% 23% 31% Total Income 775 785 786 852 838 755 841 Growth 20% 10% 14% 5% 8% -4% 7% Employee exp 151 155 153 179 179 173 198 Other op exp 174 203 212 193 200 221 218 Total op exp 325 358 365 372 379 393 416 Growth -10% -9% -12% 22% 16% 10% 14% Cost to income ratio 42.0% 45.6% 46.4% 43.7% 45.2% 52.1% 49.4% Higher on account of higher recoveries on w/off a/cs of Rs. 36Cr vs Rs. 5Cr in Opex growth stood at 14% YoY. Cost/income ratio showed an improvement sequentially improving by 267 bps to 49.4%. Employee expenses increased by 29% YoY due to higher provisions for employee retirement benefit; while other expenses increased by 3% YoY. Profit before prov. 449 427 421 480 460 361 425 Provisions 233 321 325 394 423 213 400 Growth 249% 170% 244% 81% 81% -34% 23% Credit Cost 2.28% 3.07% 3.12% 3.61% 3.75% 1.85% 3.46% Profit before tax 216 106 96 86 37 148 25 Tax 68 30 25 35-9 65 3 Profit after tax 148.0 75.6 71.5 50.6 45.9 83.7 21.2 Growth 1% -40% -38% -77% -69% 11% -70% No. of shares 60.9 60.9 72.7 72.7 72.7 79.9 79.9 EPS 2.4 1.2 1.0 0.7 0.6 1.0 0.3 Advances 42,401 44,237 44,836 45,973 47,886 48,140 47,766 Growth 8% 12% 17% 11% 13% 9% 7% CASA Ratio 29.2% 27.6% 28.1% 29.1% 30.0% 29.5% 29.8% CAR 11.7% 12.2% 13.9% 14.4% 14.1% 0.1% 0.1% Slippages 323 427 713 629 785 190 888 Slippage Ratio 3.0% 3.9% 6.4% 5.5% 6.6% 1.6% 7.4% Gross NPA 4.3% 4.8% 5.9% 6.6% 7.4% 7.7% 8.5% Net NPA 2.9% 3.2% 3.9% 4.2% 4.4% 4.4% 5.0% PCR (Calculated) 34.0% 34.1% 36.2% 38.2% 41.4% 44.7% 43.4% ROA 1.0% 0.5% 0.4% 0.3% 0.3% 0.5% 0.3% ROE 11.7% 5.8% 4.6% 3.2% 2.9% 5.3% 1.3% Source: Company data, Nirmal Bang Retail Research The quarterly provisioning rate was higher mainly on account of provisioning on the IL&FS exposure of Rs. 314 Cr. Credit cost for the quarter remained elevated at 3.5% vs 1.8% QoQ and 3.1% YoY. Retail loans exhibited a robust growth of 25% YoY contributing 19% to the overall advances. The bank chose to grow the Agri, SME and corporate book cautiously, with each contributing 17%, 35% and 28% resp. GNPAs have inched up mainly due to the IL&FS exposure slipping to NPA during the quarter. The bank contiues to witness stress on its SME book which has also resulted in higher slippages.however, the retail and the agri book continue to remain pristine. 2 P a g e

Key Conference-call highlights and our takeaways Asset Quality Gross NPAs came at Rs. 4056 Cr vs QoQ Rs. 3707 Cr at 8.5% vs QoQ 7.7% Gross slippages were at Rs. 888 Cr (7.4%) an all-time high vs QoQ Rs. 190 Cr (1.6%) & YoY Rs. 713 Cr (6.4%). Corporate gross slippages formed Rs. 484 Cr comprising of - the entire IL&FS exposure (2 entities) worth Rs. 314 Cr; one watchlist asset of Rs. 130 Cr and one restructured asset worth Rs. 40 Cr. Provisioning on IL&FS slippage has been done at 50%. SME gross slippages stood at Rs. 158 Cr. There are signs of stress visible in the SME segment and particularly in the timber industry. Earlier the bank permitted customers to pay between 0-90 dpd with a relaxed approach; however now the bank is discontinuing this practice. Over next 5 quarters, the bank has guided for following outcomes on asset quality a) Corporate book gross slippages should be at Rs. 750 Cr; SME gross slippages at Rs. 1,000 Cr; Retail & Agri gross slippages at Rs. 100 Cr totaling to gross slippages of Rs. 1850. b) Total Recovery & Upgradation of Rs. 750 Cr. c) Thus, Net Slippages of Rs. 1,100 Cr. d) On a conservative side; management has guided for a net slippages in the range of Rs. 1,100 Cr to Rs. 1,300 Cr (will be front loaded). e) This translates to a net slippage ratio of 1.8% which is not far away from the 1.5% ratio that the bank had been guiding since few quarters now. (Previous guidance was 1.5% net slippage ratio with annual absolute amount of Rs. 750 Cr). f) Calculated PCR for KVB stands at 43% which it intends to increase to ~60%. Thus credit cost would continue to be elevated in FY20E. g) Over next 5 quarters, KVB expects provisioning of ~Rs. 1,300 Cr. 3 P a g e

Other Highlights a) Loan growth for the quarter stood at 7% (Loan book of Rs. 47,766 Cr). Retail +25%, SME +9%, Agri +7% and Corporate -6%. b) Loan growth guidance: Retail will continue to grow at ~30%, SME & Agri growth will pick up to high teens and corporate growth will be in low-mid single digits. Overall loan growth guidance given by the management is of 15% for FY20E. c) As per management, opex should grow at 8-10% going forward and expenses relating to new systems will reduce from now. KVB shut 8 branches during the quarter and now has 782 branches. It also shut down a bunch of ATMs which were incurring losses. d) KVB took a write off of Rs. 434 Cr in this quarter via cash sale to ARC (no Security Receipts involved). The cash recovered was Rs. 140 Cr. 4 pillars that will drive the bank in the long term a) The bank has gained competitive advantage by adopting a comprehensive digital initiative which is fully embedded into the system. Digital initiatives have been fully embedded in SME as well. b) KVB is focusing on risk management and established a new team a few quarters back. Corporate book has shrunk 6% YoY due to this. KVB is now using external benchmarks, ratings and scorecards to ensure that quality of the book improves substantially. c) In terms of operational control, KVB has transitioned from decentralized to centralized processes. This shall free up branches so that they focus more on sales activities. d) KVB is targeting profitable growth by enhancing the product suite. Commercial credit card has gone live. The bank is targeting ~10,000 cards by end of Q4. Newly digitized risk based pricing will help expand overall yields and NIMs. 4 P a g e

View and Valuation Despite KVBs stellar performance in its core segment of Retail & SME over a decade back, its decision to aggressively grow the corporate book over FY07-12 and the subsequent stress due to defaults in the corporate book landed the bank in trouble. Since FY14, KVB has shifted its focus back towards Retail & SME. The new CEO & MD, Mr. Seshadri s extensive experience & expertise in Retail & SME shall aid KVB in improving efficiency and accelerate the pace of retailization of its loan book. The slippage and credit cost guidance given by the management during the quarter is higher than their previous guidance. To that extent we revise our estimates down and now expect FY20E to remain subdued. Although our long term thesis remains intact for KVB, any meaningful improvement in the bank s return ratios can only be expected from FY21E onwards. Sharpening focus on the retail and SME segments while building revenue as well as profit momentum (loan/pat CAGR of 14%/85%, respectively, over FY19-21E) and transformation into a granular and higher RoE business combined with cheap valuations at 1.2x FY21 ABV provides decent scope for re-rating. However, continued elevated stress in the corporate and SME book should translate to the bank recognizing this pending stress which would mean elevated credit costs for FY20E. We thus revise our rating to Hold on the stock with a price target of Rs. 90, based on 1.5x FY21E ABV (33% discount to CUB). Dupont ROE FY13 FY14 FY15 FY16 FY17 FY18E FY19E FY20E FY21E NII 2.7% 2.6% 2.8% 3.2% 3.4% 3.6% 3.5% 3.6% 3.7% Other Income 1.1% 1.1% 1.1% 1.3% 1.3% 1.4% 1.4% 1.5% 1.5% Total Income 3.8% 3.8% 3.9% 4.4% 4.7% 5.0% 4.9% 5.2% 5.2% Opex 1.8% 2.1% 2.1% 2.1% 2.1% 2.2% 2.4% 2.4% 2.4% PPP 2.0% 1.7% 1.8% 2.3% 2.6% 2.8% 2.6% 2.8% 2.8% Provisions 0.3% 0.9% 0.9% 0.7% 1.1% 2.0% 2.1% 1.4% 1.4% PBT 1.7% 0.8% 0.9% 1.6% 1.5% 0.8% 0.5% 1.3% 1.5% Tax Rate 24% 2% -7% 38% 31% 31% 31% 31% 31% ROA 1.3% 0.8% 0.9% 1.0% 1.0% 0.5% 0.4% 0.9% 1.0% Leverage 12.8 15.3 13.8 12.7 12.6 11.4 10.7 10.8 11.2 ROE 16.7% 12.1% 11.8% 12.9% 12.6% 6.1% 3.9% 10.0% 11.4% 5 P a g e

Q1FY17 Q2FY17 Q3FY17 Q4FY17 Q3FY17 Q4FY17 Story in Charts Loan Book Mix Credit Cost remains elevated 500 6.0% 18% 17% 30% Corporate SME Retail 400 300 200 100 0 2.3% 3.1% 3.1% 3.6% 3.7% 1.8% 3.5% 5.0% 4.0% 3.0% 2.0% 1.0% 35% Agri Provisions (Rs Cr) Credit Cost Muted Advances Growth Share of Corporate advances declines to 28% 60000 50000 40000 30000 20000 10000 0 6% 5% 2% 5% 8% 12% 17% 13% 11% 9% 7% 18% 16% 14% 12% 10% 8% 6% 4% 2% 0% 100% 80% 60% 40% 20% 0% 34% 33% 32% 33% 32% 31% 31% 30% 28% Advances Growth Corporate Retail+SME+Agri Corporate Net Slippages SME Net Slippages 700 600 500 400 300 200 100 0 4.0% 7.6% 16.1% 14.3% 7.2% 0.9% 7.3% 20.0% 16.0% 12.0% 8.0% 4.0% 0.0% 300 250 200 150 100 50 0 2.7% 0.9% 1.5% 1.6% 5.8% 2.4% 2.1% 8.0% 6.0% 4.0% 2.0% 0.0% Corporate Net Slippages (Rs. Cr) Corporate Net Slippage Ratio SME Net Slippages (Rs. Cr) SME Net Slippage Ratio 6 P a g e

Financials P&L (Rs. Crs) FY17 FY18 FY19E FY20E FY21E Bal. Sheet (Rs. Crs) FY17 FY18 FY19E FY20E FY21E Interest earned 5,622 5,700 5,886 6,411 7,289 Equity capital 122 145 160 160 160 Interest expended 3,549 3,402 3,476 3,756 4,258 Reserves & surplus 4,914 6,119 6,308 6,866 7,544 NII 2,074 2,298 2,410 2,656 3,030 Net worth 5,036 6,264 6,468 7,026 7,703 Non interest income 782 900 949 1,125 1,260 Deposits 53,700 56,890 60,127 67,392 77,073 Total income 2,856 3,198 3,358 3,781 4,290 (of which CASA) 14,889 16,577 18,074 20,754 24,112 Growth 15% 12% 5% 13% 13% Borrowings 1,696 2,382 1,000 1,200 1,450 Operating expenses 1,285 1,421 1,604 1,760 1,949 Other liab and prov 1,376 1,393 1,418 1,443 1,468 Growth 8% 11% 13% 10% 11% Total liabilities 56,772 60,665 62,545 70,035 79,991 Staff costs 608 639 752 826 915 Total liab and equity 61,808 66,929 69,012 77,062 87,694 Other Op Exp 677 782 852 934 1,033 Cash and bank bal 1,555 1,337 25 175 325 Profit before prov 1,571 1,777 1,755 2,021 2,342 Bal. with RBI 2,790 2,960 3,006 3,370 3,854 Growth 21% 13% -1% 15% 16% Investments 14,857 15,803 15,199 16,497 18,288 Provisions 687 1,274 1,396 1,040 1,117 Net Advances 40,908 44,800 48,611 54,698 62,742 Growth 85% 85% 10% -25% 7% Growth 5% 10% 9% 13% 15% Profit before tax 884 503 359 981 1,224 Other assets 1,697 2,029 2,171 2,323 2,485 Taxes 278 158 112 307 383 Total assets 61,808 66,929 69,012 77,062 87,694 Net profit 606 346 247 674 841 Growth 7% -43% -29% 173% 25% Asset Quality FY17 FY18 FY19E FY20E FY21E GNPA 1,484 3,016 4,198 5,078 6,058 Key Ratios FY17 FY18 FY19E FY20E FY21E GNPA ratio 6.6% 8.4% 9.0% 9.4% 9.4% Yield on Advances 11.3% 10.3% 9.7% 9.8% 9.9% NNPA 1,033 1,863 2,296 2,686 3,048 Yield on Tot Assets 9.6% 9.1% 8.9% 9.1% 9.1% NNPA ratio 2.5% 4.2% 4.7% 4.9% 4.9% Cost of Borrowings 6.5% 5.9% 5.8% 5.8% 5.8% PCR (Calculated) 30% 38% 45% 47% 50% Spread 4.82% 4.39% 3.96% 4.03% 4.09% Credit Cost 1.7% 2.9% 2.9% 2.0% 1.9% NIM 3.70% 3.80% 3.62% 3.71% 3.75% Balance Sheet Ratios FY17 FY18 FY19E FY20E FY21E Profitability Ratios FY17 FY18 FY19E FY20E FY21E CD Ratio 76.2% 78.7% 80.8% 81.2% 81.4% Cost / Income Ratio 45.0% 44.4% 47.7% 46.5% 45.4% CASA 27.7% 29.1% 30.1% 30.8% 31.3% ROE 12.0% 6.1% 3.9% 10.0% 11.4% CAR 12.5% 14.4% 14.5% 14.0% 13.4% ROA 1.00% 0.54% 0.36% 0.92% 1.02% Tier - 1 11.9% 13.9% 14.0% 13.5% 12.9% Per Share Data FY17 FY18 FY19E FY20E FY21E Valuation Ratios FY17 FY18 FY19E FY20E FY21E EPS 9.9 4.8 3.1 8.4 10.5 P/E 6.7 14.1 21.7 7.9 6.4 BVPS 82.6 86.2 80.9 87.9 96.4 P/BV 0.8 0.8 0.8 0.8 0.7 Adjusted BVPS 65.7 60.6 52.2 54.3 58.2 P/ABV 1.0 1.1 1.3 1.2 1.2 Source: Company data, NBRR 7 P a g e

Disclosure: This Report is published by Nirmal Bang Securities Private Limited (hereinafter referred to as NBSPL ) for private circulation. NBSPL is a registered Research Analyst under SEBI (Research Analyst) Regulations, 2014 having Registration no. INH000001766. NBSPL is also a registered Stock Broker with National Stock Exchange of India Limited and BSE Limited in cash and derivatives segments. It is also a registered Portfolio Manager having registration no as INP000002981. NBSPL has other business divisions with independent research teams separated by Chinese walls, and therefore may, at times, have different or contrary views on stocks and markets. NBSPL or its associates have not been debarred / suspended by SEBI or any other regulatory authority for accessing / dealing in securities Market. NBSPL, its associates or analyst or his relatives do not hold any financial interest in the subject company. NBSPL or its associates or Analyst do not have any conflict or material conflict of interest at the time of publication of the research report with the subject company. NBSPL or its associates or Analyst or his relatives hold / do not hold beneficial ownership of 1% or more in the subject company at the end of the month immediately preceding the date of publication of this research report. NBSPL or its associates / analyst has not received any compensation / managed or co-managed public offering of securities of the company covered by Analyst during the past twelve months. NBSPL or its associates have not received any compensation or other benefits from the company covered by Analyst or third party in connection with the research report. Analyst has not served as an officer, director or employee of Subject Company and NBSPL / analyst has not been engaged in market making activity of the subject company. Analyst Certification: I, Jehan Bhadha, the research analyst and author of this report, hereby certify that the views expressed in this research report accurately reflects my/our personal views about the subject securities, issuers, products, sectors or industries. It is also certified that no part of the compensation of the analyst(s) was, is, or will be directly or indirectly related to the inclusion of specific recommendations or views in this research. The analyst(s) principally responsible for the preparation of this research report and has taken reasonable care to achieve and maintain independence and objectivity in making any recommendations. 8 P a g e

Disclaimer: This report is for the personal information of the authorized recipient and does not construe to be any investment, legal or taxation advice to you. NBSPL is not soliciting any action based upon it. Nothing in this research shall be construed as a solicitation to buy or sell any security or product, or to engage in or refrain from engaging in any such transaction. In preparing this research, we did not take into account the investment objectives, financial situation and particular needs of the reader. This research has been prepared for the general use of the clients of NBSPL and must not be copied, either in whole or in part, or distributed or redistributed to any other person in any form. If you are not the intended recipient you must not use or disclose the information in this research in any way. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. NBSPL will not treat recipients as customers by virtue of their receiving this report. This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject NBSPL & its group companies to registration or licensing requirements within such jurisdictions. The report is based on the information obtained from sources believed to be reliable, but we do not make any representation or warranty that it is accurate, complete or up-to-date and it should not be relied upon as such. We accept no obligation to correct or update the information or opinions in it. NBSPL or any of its affiliates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. NBSPL or any of its affiliates or employees do not provide, at any time, any express or implied warranty of any kind, regarding any matter pertaining to this report, including without limitation the implied warranties of merchantability, fitness for a particular purpose, and non-infringement. The recipients of this report should rely on their own investigations. This information is subject to change without any prior notice. NBSPL reserves its absolute discretion and right to make or refrain from making modifications and alterations to this statement from time to time. Nevertheless, NBSPL is committed to providing independent and transparent recommendations to its clients, and would be happy to provide information in response to specific client queries. Before making an investment decision on the basis of this research, the reader needs to consider, with or without the assistance of an adviser, whether the advice is appropriate in light of their particular investment needs, objectives and financial circumstances. There are risks involved in securities trading. The price of securities can and does fluctuate, and an individual security may even become valueless. International investors are reminded of the additional risks inherent in international investments, such as currency fluctuations and international stock market or economic conditions, which may adversely affect the value of the investment. Opinions expressed are subject to change without any notice. Neither the company nor the director or the employees of NBSPL accept any liability whatsoever for any direct, indirect, consequential or other loss arising from any use of this research and/or further communication in relation to this research. Here it may be noted that neither NBSPL, nor its directors, employees, agents or representatives shall be liable for any damages whether direct or indirect, incidental, special or consequential including lost revenue or lost profit that may arise from or in connection with the use of the information contained in this report. Copyright of this document vests exclusively with NBSPL. Our reports are also available on our website www.nirmalbang.com. Nirmal Bang Research (Division of Nirmal Bang Securities Pvt. Ltd.) B-2, 301/302, Marathon Innova, Opp. Peninsula Corporate Park, Off Ganpatrao Kadam Marg, Lower Parel (W), Mumbai-400013 Board No. : 91 22 3926 8000/8001 Fax. : 022 3926 8010 9 P a g e